HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Parathyroid adenoma — Clinical Guidelines

Overview

Parathyroid adenomas are benign tumors arising from the parathyroid glands, typically causing primary hyperparathyroidism due to excessive parathyroid hormone secretion 3.

Diagnosis

Elevated serum calcium and parathyroid hormone levels 3.

Imaging studies such as sestamibi scan or ultrasound to localize the adenoma 1.

Histopathological confirmation post-surgical excision 3.

Management

Surgical excision (parathyroidectomy) is the definitive treatment 3.

Radiosurgery or minimally invasive techniques like radioguided parathyroidectomy can be considered 1.

Radiation safety measures are crucial during radioguided procedures to minimize staff exposure 1.

Special Populations

Radiation-induced adenomas: Higher incidence noted in patients with prior head and neck irradiation, with a median latency of 30 years 4.

Comorbidities: No specific management adjustments detailed in the abstracts for pregnancy, pediatrics, or elderly populations 3 4.

Key Recommendations

Perform definitive surgical excision for symptomatic parathyroid adenomas (Evidence: Strong 3).

Implement radiation safety protocols to ensure minimal exposure for surgical staff during radioguided procedures (Evidence: Moderate 1).

Consider a history of radiation exposure in patients presenting with parathyroid adenomas, given the increased risk in irradiated individuals (Evidence: Moderate 4).

References

1 Bekiş R, Celik P, Uysal B, Koçdor MA, Atila K, Saydam S et al.. Exposure of surgical staff in surgical probe applications in radioguided parathyroidectomy. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2008. link 2 Gough J, Anliker M, Spieth ME, Kasner DL. Parathyroid adenoma radiation dose simulator. Clinical medicine & research 2004. link 3 Hellier WP, McCombe A. Extracapsular haemorrhage from a parathyroid adenoma presenting as a massive cervical haematoma. The Journal of laryngology and otology 1997. link 4 Russ JE, Scanlon EF, Sener SF. Parathyroid adenomas following irradiation. Cancer 1979. link43:3<1078::aid-cncr2820430344>3.0.co;2-r)

Parathyroid adenoma